Oncopharmpod
ESMO 2022 - NICHE-2 and Codebreak 200
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:11:41
- More information
Informações:
Synopsis
ESMO 2022 is wrapped and two studies in particular have caught our eyes: NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer CODEBREAK: sotorasib vs. docetaxel
